1. Home
  2. ELUT vs CIGL Comparison

ELUT vs CIGL Comparison

Compare ELUT & CIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elutia Inc.

ELUT

Elutia Inc.

HOLD

Current Price

$1.07

Market Cap

50.8M

Sector

Health Care

ML Signal

HOLD

CIGL

Concorde International Group Ltd Class A Ordinary Shares

SELL

Current Price

$1.72

Market Cap

47.8M

ML Signal

SELL

Company Overview

Basic Information
Metric
ELUT
CIGL
Founded
2015
1997
Country
United States
Singapore
Employees
N/A
134
Industry
Medical Specialities
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.8M
47.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ELUT
CIGL
Price
$1.07
$1.72
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
172.6K
69.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
10.14
N/A
EPS
N/A
N/A
Revenue
$24,375,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$1.40
52 Week High
$3.46
$25.00

Technical Indicators

Market Signals
Indicator
ELUT
CIGL
Relative Strength Index (RSI) 53.01 46.65
Support Level $0.86 $1.54
Resistance Level $1.15 $2.20
Average True Range (ATR) 0.14 0.18
MACD -0.01 0.00
Stochastic Oscillator 13.24 46.15

Price Performance

Historical Comparison
ELUT
CIGL

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About CIGL Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.

Share on Social Networks: